Hanmi Science Jumps Amid Power Struggle Over Corporate Control[K-BIO Pulse]

[Kim Jiwan, Edaily Reporter] On the 24th Korea’s pharmaceutical and biotech sector moved into the market spotlight as corporate control disputes breakthrough drug development results and rising order backlogs converged to drive strong gains across bio and healthcare stocks.

Hanmi Science surged on escalating governance tensions Hyundai ADM rallied on breakthroughs in overcoming cancer drug resistance while Biotoxtech gained momentum on expectations of a sharp earnings turnaround backed by a massive order backlog.

◇Hanmi Science jumps on control dispute Shares of Hanmi Science posted a sharp rally as news of deepening management conflict surfaced.